0413B |
Brodifacoum (Qualitative), Blood |
0420B |
Betahydroxybutyric Acid, Blood |
0420FL |
Betahydroxybutyric Acid, Fluid |
0500B |
Barbital, Blood |
0512B |
Barbiturates Screen, Blood |
0519B |
Barium, Blood |
0519TI |
Barium, Tissue |
0520B |
Belladonna Alkaloids Panel, Blood |
0541B |
Benzene, Blood |
0541TI |
Benzene, Tissue |
0568B |
Benzodiazepines Screen, Blood |
0568FL |
Benzodiazepines Screen, Fluid |
0585B |
Benzonatate, Blood |
0610B |
Benzphetamine as Metabolites, Blood |
0620B |
Benztropine, Blood |
0620TI |
Benztropine, Tissue |
0630B |
Benzyl Alcohol, Blood |
0638B |
Beryllium, Blood |
0645FL |
Bicarbonate, Fluid |
0680B |
Bismuth, Blood |
0711B |
Boron, Blood |
0718B |
Brivaracetam, Blood |
0719B |
Bromazolam, Blood |
0720B |
Bromine - Total, Blood |
0770B |
Brompheniramine, Blood |
0771B |
Brorphine, Blood |
0796B |
Bumetanide, Blood |
0800B |
Bupivacaine, Blood |
0800FL |
Bupivacaine, Fluid |
0801B |
Buprenorphine and Metabolite - Free (Unconjugated), Blood |
0802B |
Buprenorphine and Metabolite - Free (Unconjugated) Screen, Blood |
0803B |
Bupropion and Metabolite, Blood |
0803FL |
Bupropion and Metabolite, Fluid |
0803TI |
Bupropion and Metabolite, Tissue |
0805B |
Buspirone, Blood |
0810B |
Butabarbital, Blood |
0830B |
Butalbital, Blood |
0835B |
Butane and Isobutane, Blood |
0850B |
Butanols, n-, iso-, Sec- and Tert, Blood |
0885B |
Butorphanol - Free (Unconjugated), Blood |
2111B |
Baclofen, Blood |
2111FL |
Baclofen, Fluid |
2626B |
Bath Salts Panel (Qualitative), Blood |
3227B |
Beta-Blockers Panel, Blood |
8620B |
Barbiturates Panel, Blood |
8620FL |
Barbiturates Panel, Fluid |
8620TI |
Barbiturates Panel, Tissue |
9118B |
Brompheniramine Screen, Blood |
9122B |
Bupropion and Metabolite Screen, Blood |
9122TI |
Bupropion and Metabolite Screen, Tissue |
9329B |
Benzodiazepines Panel, Blood |
9329FL |
Benzodiazepines Panel, Fluid |
9329TI |
Benzodiazepines Panel, Tissue |
9351UC |
Basic Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |